Vision-Sciences, Inc. Announces Record Revenues Of $5.0 Million For Fourth Quarter And $17.1 Million For Full Year Fiscal 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ORANGEBURG, N.Y., April 28, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the fourth quarter and full year fiscal 2014, ended March 31, 2014.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC